CLMT

Calumet Inc

Add to Watchlist

Advanced Chart

16.870

-0.27(-1.575%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

17.170

Open

17.170

VWAP

16.87

Vol

542.61K

Mkt Cap

1.46B

Low

16.430

Amount

9.15M

EV/EBITDA(TTM)

189.04

Total Shares

86.62M

4.27B

EV/OCF(TTM)

P/S(TTM)

0.34

Calumet, Inc. manufactures, formulates and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. Its segments include Specialty Products and Solutions; Performance Brands; Montana/Renewables, and Corporate. Specialty Products and Solutions segment manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, petrolatum, gels, esters, and other products. Performance Brands segment blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. Montana/Renewables segment comprises two facilities: renewable fuels and specialty asphalt. At its Montana Renewables facility, it processes a variety of geographically advantaged renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha that are distributed into renewables markets.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

1.20B

+6.1%

-0.220

-32.1%

1.21B

+10.27%

0.040

-107.72%

1.21B

+27.8%

-0.360

+108.21%

Estimates Revision

The market is revising No Change the revenue expectations for Calumet, Inc. (CLMT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 52.33%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+52.33%

In Past 3 Month

4 Analyst Rating

46.24% Upside

Wall Street analysts forecast CLMT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLMT is 24.67 USD with a low forecast of 20.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

46.24% Upside

Current: 16.870

Low

20.00

Averages

24.67

High

33.00

46.24% Upside

Current: 16.870

Low

20.00

Averages

24.67

High

33.00

BofA

Buy

maintain

$15 -> $20

2025-06-17

Reason

BofA

Price Target

$15 -> $20

2025-06-17

maintain

Buy

Reason

BofA raised the firm's price target on Calumet to $20 from $15 and keeps a Buy rating on the shares after the EPA proposed a total renewable volume obligation of 24.02B renewable identification numbers for 2026. The RVO is positive for Calumet, says the analyst, who notes that the higher RVO corresponds to a 20c per gallon higher margin on the cost curve than the firm's prior expectation. The firm raised its price target due to higher surety for demand and higher margins in the near-to-longer term, the analyst tells investors.

Wells Fargo

Overweight

downgrade

$23 -> $21

2025-05-14

Reason

Wells Fargo

Price Target

$23 -> $21

2025-05-14

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on Calumet to $21 from $23 and keeps an Overweight rating on the shares. The firm says the Path to MaxSAF remains on schedule, but more importantly, significantly cheaper. Potential dispositions provide a bridge for any debt reduction, Wells adds.

BofA

Conor Fitzpatrick

Buy

initiated

$15

2025-05-13

Reason

BofA

Conor Fitzpatrick

Price Target

$15

2025-05-13

initiated

Buy

Reason

BofA analyst Conor Fitzpatrick initiated coverage of Calumet with a Buy rating and $15 price target. The oil refiner and biofuel producer is progressing its biofuel business Montana Renewables' MaxSAF project to expand renewable jet fuel capacity, notes the analyst, who expects MaxSAF to roughly double EBITDA between 2025 and 2027. Renewables growth should drive deleveraging, the analyst added.

Wells Fargo

Roger Read

Buy

Maintains

$28 → $23

2025-04-09

Reason

Wells Fargo

Roger Read

Price Target

$28 → $23

2025-04-09

Maintains

Buy

Reason

Wells Fargo analyst Roger Read lowered the firm's price target on Calumet to $23 from $28 and keeps an Overweight rating on the shares. The firm cites reduced valuation multiples in its sum-of-the-parts, which reflects increased uncertainty on the timing of the RD recovery/PTC clarity and economic outlook for Specialties & Performance Brands.

UBS

Manav Gupta

Strong Sell

Hold

Upgrades

$15 → $12

2025-03-17

Reason

UBS

Manav Gupta

Price Target

$15 → $12

2025-03-17

Upgrades

Strong Sell

Hold

Reason

UBS analyst Manav Gupta upgraded Calumet to Neutral from Sell with a price target of $12, down from $15. The firm believes the current stock price better reflects the company's downside earnings risk as well as its weaker organic free cash flow generation ability. The stock is down 45% year-to-date, as the market now better understands the risk associated with the policy going from Blender's tax credit to production tax credit, the analyst tells investors in a research note.

Wells Fargo

Roger Read

Buy

Maintains

$29 → $28

2025-03-05

Reason

Wells Fargo

Roger Read

Price Target

$29 → $28

2025-03-05

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Calumet Inc (CLMT.O) is -22.49, compared to its 5-year average forward P/E of -5.26. For a more detailed relative valuation and DCF analysis to assess Calumet Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-5.26

Current PE

-22.49

Overvalued PE

23.28

Undervalued PE

-33.79

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued

5Y Average EV/EBITDA

10.90

Current EV/EBITDA

16.26

Overvalued EV/EBITDA

13.91

Undervalued EV/EBITDA

7.90

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.31

Current PS

0.37

Overvalued PS

0.45

Undervalued PS

0.18